CMS Finalizes Guidance on Medicare Part D Manufacturer Discount Program
FDA Law Blog
DECEMBER 3, 2023
covered insulin product or vaccine). Each phase-in policy allows eligible manufacturers to build up in a stepwise manner to the 10% and 20% applicable discounts by 2029 and 2031, respectively. CMS will require participating manufacturers to submit and attest to this ownership information in the Health Plan Management System (HPMS).
105 
Let's personalize your content